Billionaire Investor David Einhorn has sent the chilling warning that stock markets are in the midst of a bubble which is on the verge of collapsing. He has given 10 reasons to support his hypothesis
Subscribe to Blog via Email
Join 505 other subscribers
- Adani Ports is very well placed to continue to outpace industry growth & gain market shareAdani Ports is very well placed to continue to outpace industry growth & gain market share. The integration of the logistics business with the ports business is enhancing its service offerings & transforming the Co into a transport utility. TP ₹1530 (29%) Download research report... Adani Ports is very well placed to continue to outpace […]
- Archean is a robust play on the expanding footprint in high-growth derivative & technology sectors.Archean is a robust play on the expanding footprint in high-growth derivative & technology sectors. Worst seems to be behind it. Co is set to capitalize on favorable macroeconomic trends & is an attractive investment for long-term value creation. TP ₹840 Download research... Archean is a robust play on the expanding footprint in high-growth derivative […]
- Pearl Global (PGIL) is a perfect candidate for a valuation re-ratingPGIL is a perfect candidate for a valuation re-rating given its execution capabilities, growth opportunities, and quality management. With all growth levers in place and multiple industry tailwinds, PGIL will be one of the foremost beneficiaries Download research report... Pearl Global (PGIL) is a perfect candidate for a valuation re-rating
Recent Posts
- Adani Ports is very well placed to continue to outpace industry growth and gain market share. Buy for target price of ₹1530 (29% upside): Motilal Oswal
- Archean Chemical Industries is a robust play on the recovery in bromine and industrial salt markets. Buy for target price of ₹840 (19% upside): Chola Securities
- PGIL is a perfect candidate for a valuation re-rating given its execution capabilities, growth opportunities, and quality management: Nuvama
- List of 12 Quality Stocks with high dividend yield from 3.2% to 10.9% by IDBI Capital
- IPCA Laboratories’ brand-building strength is poised to drive outperformance. Buy for target price of ₹1800 (20% upside): HDFC Securities
Recent Comments